March 20 (Reuters) - The U.S. Food and Drug Administration said on Friday it approved Bristol Myers Squibb's combination ...
VCU Massey is the first U.S. site in a global phase 2a trial for PTX-100, targeting cutaneous T-cell lymphoma. The BIPAVE-001 trial is evaluating AI-081, a PD-1 and VEGF bispecific antibody, for ...
Add Yahoo as a preferred source to see more of our stories on Google. Sullivan, 82, detailed her experience undergoing chemotherapy for the lymphoma, which is a type of blood cancer. "At first it was ...
Anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) represents a distinct molecular subset of lung cancers, predominantly affecting a younger demographic with limited smoking ...
Fifteen-year follow-up from the S0016 trial suggests that some patients with advanced-stage follicular lymphoma may be cured with standard chemoimmunotherapy, according to Dr. Jonathan W. Friedberg, ...
Dr. Jeffrey Yang from Mass. General Brigham discusses some of the new risk factors for lung cancer, many of which don't even involve smoking.
On top of the fear and grief in learning that you have an aggressive form of cancer, you’ll have many appointments, some directly related to your treatment and others to help you with the financial, ...
The Falcon Crest actress said she is "sort of on hold," but she adds, "I feel good." The Castle star's doctors have recommended quarterly infusion therapy. Susan Sullivan is doing well two years after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results